Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary-Reference-Cited by-同舟云学术

Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary

Published:2020-04-01 Issue:4 Volume:180 Page:597
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Feldman William B.¹²³,Rome Benjamin N.¹³,Lehmann Lisa Soleymani³⁴⁵,Kesselheim Aaron S.¹³

Affiliation:

1. Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts

2. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts

3. Harvard Medical School, Boston, Massachusetts

4. US Department of Veteran Affairs, New England Healthcare System, Boston, Massachusetts

5. Harvard T. H. Chan School of Public Health, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2759734/jamainternal_feldman_2020_ld_190068.pdf

Reference6 articles.

1. Assessment of spending in Medicare Part D If Medication prices from the Department of Veterans Affairs were used.;Venker;JAMA Intern Med,2019

2. Potential Medicare savings on inhaler prescriptions through the use of negotiated prices and a defined formulary;Feldman;JAMA Intern Med

3. Centers of Medicare & Medicaid Services. Medicare Part D drug spending dashboard and data. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Information-on-Prescription-Drugs/MedicarePartD.html. Accessed November 26, 2019.

4. US Department of Veterans Affairs. Freedom of Information Act (FOIA) library. https://www.va.gov/oal/business/pps/foiaLibrary.asp#four. Accessed November 26, 2019.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicare Patients Face High Out-of-Pocket Costs for Specialty Inflammatory Bowel Disease Medications;American Journal of Gastroenterology;2022-10-11

2. Economic Evaluation of the $35 Insulin Copay Cap Policy in Medicare and Its Implication for Future Interventions;Diabetes Care;2022-09-12

3. Branded Price Variation in the United States Drug Market, 2010 to 2019;Value in Health;2021-09

4. Cost to Medicare of Delayed Adalimumab Biosimilar Availability;Clinical Pharmacology & Therapeutics;2021-07-06

5. Estimating Rebates and Other Discounts Received by Medicare Part D;JAMA Health Forum;2021-06-04